This inventor holds 41 USPTO granted patents and 35 published patent applications, primarily in Tamper Resistant Dosage Forms. Top assignees: Purdue Pharma L.p., Purdue Pharmaceuticals L.p., Other. Active years: 2014-2025.
Company Filing History:
40 out of 547Â 
34 out of 77Â 
1 out of 834,411Â Years Active: 2014-2025
Areas of Expertise:
Title: The Ingenious Inventor: William H McKenna
Introduction
William H McKenna, a prolific inventor hailing from Yonkers, NY, has left an indelible mark in the realm of pharmaceutical innovations. With an impressive portfolio of 37 patents to his name, McKenna's inventive prowess continues to shape the landscape of pharmaceutical dosage forms.
Latest Patents
Among his latest patents is the groundbreaking work on tamper-resistant dosage forms. McKenna's ingenuity shines in the creation of pharmaceutical dosage forms, particularly in developing tamper-resistant formulations that include opioid analgesics. These inventions not only revolutionize drug delivery but also enhance patient safety through innovative packaging and design.
Career Highlights
McKenna has made significant contributions during his tenure at renowned pharmaceutical companies such as Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. His expertise and dedication to innovation have propelled him to the forefront of the industry, where his patents have garnered acclaim for their ingenuity and practical application in healthcare.
Collaborations
Collaborating with esteemed colleagues like Richard O Mannion and Edward P O'Donnell, McKenna has leveraged collective expertise to push the boundaries of pharmaceutical research and development. Together, they have spearheaded projects that have redefined best practices in drug formulation and delivery.
Conclusion
In conclusion, William H McKenna stands as a beacon of innovation in the field of pharmaceuticals, with a remarkable track record of patent successes. His pioneering work in tamper-resistant dosage forms underscores his commitment to advancing healthcare solutions that prioritize patient well-being. As McKenna's legacy continues to inspire future generations of inventors, his contributions remain pivotal in shaping the future of pharmaceutical innovations.